Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis.
about
Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.Ceftriaxone protects against tobramycin nephrotoxicityEffectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administrationIn vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for ReEffect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococciPharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.Swedish guidelines for diagnosis and treatment of infective endocarditis.Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis.Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditisEffect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillinTemporal variation in nephrotoxicity of low doses of isepamicin in rats.Outpatient treatment of endocarditis in a clinic-based program in Argentina.
P2860
Q28345165-E5E827E4-0C6A-4702-8636-4A055BC561AFQ28369285-363F454D-0758-4194-998F-7BB83BA0D180Q33976169-0857F8CF-119B-4F68-B3E6-3B8A1D5E2BF2Q35119461-4D8179A5-0FB4-46F2-AC21-8432077889FEQ35124179-B1CC56A4-CD32-4562-964C-E6AE21804D63Q35130544-4B53B71F-98BA-4460-8687-5396D7BE175DQ35138989-8E63E9FF-EBCB-42A7-894B-9700B1B26914Q35819639-16B00058-F11B-4135-B18D-0FFDB60A0A8EQ37008713-E3D60A76-20ED-4547-A776-65D9F981A18FQ38892614-52BA4095-D531-41C9-AE76-5E9FBFD3622CQ39477095-FA9E63AD-B7D1-4FCB-80DC-D6FB1959FAAAQ39780462-A4871A21-F9EC-47F3-BC7E-E7C676CE87BCQ39781726-4167E904-B357-4AB0-9D15-08A23CEAA834Q40432521-D4D06EDB-4F69-437C-AB8A-2F8095B374C0
P2860
Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Synergistic activity of ceftri ...... al streptococcal endocarditis.
@ast
Synergistic activity of ceftri ...... al streptococcal endocarditis.
@en
type
label
Synergistic activity of ceftri ...... al streptococcal endocarditis.
@ast
Synergistic activity of ceftri ...... al streptococcal endocarditis.
@en
prefLabel
Synergistic activity of ceftri ...... al streptococcal endocarditis.
@ast
Synergistic activity of ceftri ...... al streptococcal endocarditis.
@en
P2860
P356
P1476
Synergistic activity of ceftri ...... al streptococcal endocarditis.
@en
P2093
Francioli PB
Glauser MP
P2860
P304
P356
10.1128/AAC.37.2.207
P407
P577
1993-02-01T00:00:00Z